GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

The study replicated the methodology used for the U.S. formula, focusing on L-cells in the colon, which naturally produce the GLP-1 hormone. Researchers examined several genes tied to GLP-1 ...

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the ... Neurotech Pharma's cell therapy Encelto has become the first FDA-approved therapy for ...

"On the other hand, the fact that receptors for GLP-1 are present on subsets of immune cells means that, until we have deeper knowledge, the effects of these drugs on inflammatory responses are ...

In recent years, the growing list of medical benefits for GIP and GLP-1 agonists (think Ozempic for diabetes or Zepbound for weight loss, among others) has caused demand to skyrocket ...

THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients ...

Related Cosmetic surgeons try to correct 'Ozempic face' for weight-loss drug users Massive study looks at benefits, risks of GLP-1 weight-loss drugs FDA says shortage of GLP-1 drug tirzepatide is ...

However, some studies in mice models have shown reductions in astrogliosis and retinal ganglion cell loss." GLP-1 drugs have also demonstrated neuroprotection, Vasu noted. "Reductions in ...

Working with a weight management program can help sustain the use of GLP-1 therapies and address potential side effects. Patient education and expectation management are crucial for maximizing ...

SCFAs stimulate L-cells in your intestines to release satiety hormones like GLP-1, PYY (peptide YY), and CCK,” he added. However, the effect is modest, temporary appetite reduction - not the ...

Opens in a new tab or window Patients using GLP-1 drugs had no difference ... adjusted analysis (OR 0.78, 95% CI 0.57-1.06, P=0.12), reported Eric L. Smith, MD, of New England Baptist Hospital ...